scholarly journals Application of Anti-PD-L1 Monoclonal Antibody Atezolizumab in Second Line Therapy of Common Urothelial Bladder Cancer

2019 ◽  
Vol 15 (38) ◽  
pp. 30-34
Author(s):  
S.S. Sidorova ◽  
◽  
D.M. Ponomarenko ◽  
D.Yu. Yukalchuk ◽  
S.P. Sidorov ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Bladder Cancer ◽  
Second Line ◽  
Urothelial Bladder Cancer ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Urothelial Bladder

scholarly journals FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients

2015 ◽  
Vol 46 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Chandragouda Dodagoudar ◽  
Dinesh Chandra Doval ◽  
Anupam Mahanta ◽  
Varun Goel ◽  
Amitabh Upadhyay ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Gall Bladder ◽  
Cancer Patients ◽  
Gall Bladder Cancer ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Advanced Gall Bladder Cancer

Second-line therapy in bladder cancer

2009 ◽  
Vol 19 (5) ◽  
pp. 533-539 ◽  
Author(s):  
Mark Bachner ◽  
Maria De Santis
Keyword(s):  
Bladder Cancer ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy—The Global DISCOVER Study

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1629-P
Author(s):  
KAMLESH KHUNTI ◽  
HUNGTA CHEN ◽  
JAVIER CID-RUZAFA ◽  
PETER FENICI ◽  
MARILIA B. GOMES ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document